Wholesale of pharmaceutical and medical goods
RETHINK PHARMA AS
Revenue 2024
NOK 495
Operating profit
NOK −1,000
Equity
NOK −275,000
Incorporated
2021
Share capital
NOK 30,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 495 | |
| Total operating costs | 2k | |
| Operating profit (EBIT) | −1k | |
| Net financial items | −51 | |
| Profit for the year | −1k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 431k | |
| of which current assets | 431k | |
| Equity | −275k | |
| Total liabilities | 706k |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.